176 related articles for article (PubMed ID: 16140545)
1. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.
Wang RF
Semin Cancer Biol; 2006 Feb; 16(1):73-9. PubMed ID: 16140545
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors and immune regulation: implications for cancer therapy.
Wang RF; Miyahara Y; Wang HY
Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells and cancer.
Wang HY; Wang RF
Curr Opin Immunol; 2007 Apr; 19(2):217-23. PubMed ID: 17306521
[TBL] [Abstract][Full Text] [Related]
5. Functional control of regulatory T cells and cancer immunotherapy.
Wang RF
Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
Liu G; Zhao Y
Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
[TBL] [Abstract][Full Text] [Related]
7. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
Orentas RJ; Kohler ME; Johnson BD
Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
[TBL] [Abstract][Full Text] [Related]
8. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
9. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells and toll-like receptors in cancer therapy.
Wang RF
Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
[TBL] [Abstract][Full Text] [Related]
11. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
12. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
13. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
[TBL] [Abstract][Full Text] [Related]
14. The significance of Treg cells in defective tumor immunity.
Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
[TBL] [Abstract][Full Text] [Related]
15. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
Masteller EL; Tang Q; Bluestone JA
Semin Immunol; 2006 Apr; 18(2):103-10. PubMed ID: 16458533
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring self-reactive CD4+CD25+ regulatory T cells: universal immune code.
Pakravan N; Hassan AT; Hassan ZM
Cell Mol Immunol; 2007 Jun; 4(3):197-201. PubMed ID: 17601373
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors: paving the path to T cell-driven autoimmunity?
Marsland BJ; Kopf M
Curr Opin Immunol; 2007 Dec; 19(6):611-4. PubMed ID: 17888644
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
[TBL] [Abstract][Full Text] [Related]
20. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
Chen W; Ford MS; Young KJ; Zhang L
Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]